Company Filing History:

7 out of 36

Immuno Aktiengesellschaft Fur Chemisch-medizinische Produkte

patents

5 out of 83

Immuno Aktiengesellschaft

patents

3 out of 67

Baxter Aktiengesellschaft

patents

4. 1 out of 832,680

Other

patents

Years Active: 1981-2007

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7241603 - Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method (2007-07-10),

2. 6649162 - Hemostatic sponge based on collagen (2003-11-18),

3. 6579537 - Method for producing fibronectin and fibrinogen compositions using a polyalkylene glycol and glycine or &bgr;-alanine (2003-06-17),

4. 6548729 - Fibrin sponge (2003-04-15),

5. 5962405 - Storage-stable fibrinogen preparations (1999-10-05),

6. 5883078 - Hemostyptic and tissue adhesive (1999-03-16),

7. 5733885 - Method of producing a virus-safe biological preparation (1998-03-31),

8. 5639730 - Method of producing a virus-safe biological preparation (1997-06-17),

9. 5610147 - Virus-safe blood coagulation factor XIII preparation (1997-03-11),

10. 4909251 - Tissue adhesive (1990-03-20),

11. 4816251 - Method of inactivating reproductive filterable pathogens in fibrinogen (1989-03-28),

12. 4735616 - Arrangement for applying a tissue adhesive (1988-04-05),

13. 4414976 - Tissue adhesive (1983-11-15),

14. 4377572 - Tissue adhesive (1983-03-22),

15. 4362567 - Tissue adhesive (1982-12-07),

Title: Thomas Seelich: Pioneering Innovator Shaping the Future

Introduction:

Thomas Seelich, a visionary inventor based in Vienna, Austria, is renowned for his groundbreaking contributions to the world of inventions. With a total of 16 patents to his name, Seelich combines expertise with a passion for innovation, driving advancements in technology for a brighter tomorrow.

Latest Patents:

Among his recent patents, Thomas Seelich has introduced revolutionary ideas such as the Method for producing a preparation based on fibrinogen and fibronectin. This innovative method involves treating a fibrinogen and fibronectin-containing solution with a unique precipitating composition, resulting in the formation of protein compositions essential for various applications. Additionally, his creation of the Hemostatic sponge based on collagen represents a significant advancement in the field of medical technology, providing a vital tool for promoting blood coagulation in emergency situations.

Career Highlights:

Thomas Seelich has made significant contributions during his tenure at companies like Immuno Aktiengesellschaft für chemisch-medizinische Produkte and Immuno Aktiengesellschaft. His innovative spirit and expertise have been instrumental in driving forward the development of cutting-edge solutions in the medical and healthcare sectors.

Collaborations:

Throughout his career, Thomas Seelich has collaborated closely with esteemed colleagues such as Otto Schwarz and Yendra Linnau. These partnerships have not only fostered a culture of innovation but have also led to the successful implementation of groundbreaking ideas in the realm of inventions.

Conclusion:

In conclusion, Thomas Seelich's remarkable journey as an inventor underscores his unwavering commitment to pushing the boundaries of innovation. His pioneering work not only inspires future generations of inventors but also leaves an indelible mark on the ever-evolving landscape of technology and inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.